Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa

OBJECTIVE: WHO recommends ritonavir-boosted protease inhibitor with two nucleoside reverse transcriptase inhibitors in HIV-infected patients failing non-nucleoside reverse transcriptase inhibitor-based first-line treatment. Here, we aimed to provide more evidence for the choice of nucleoside reverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciaffi, Laura, Koulla-Shiro, Sinata, Sawadogo, Adrien, le Moing, Vincent, Eymard-Duvernay, Sabrina, Izard, Susanne, Kouanfack, Charles, Ngom Gueye, Ndeye Fatou, Fobang, Avelin Aghokeng, Reynes, Jacques, Calmy, Alexandra, Delaporte, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502989/
https://www.ncbi.nlm.nih.gov/pubmed/26244387
http://dx.doi.org/10.1097/QAD.0000000000000709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502989/
https://www.ncbi.nlm.nih.gov/pubmed/26244387
http://dx.doi.org/10.1097/QAD.0000000000000709

Ejemplares similares